Red raspberry leaf (Rubus idaeus)
Also called raspberry leaf, red raspberry leaf tea, raspberry leaf tea, Rubus idaeus, European raspberry, European red raspberry.
Best grade C across 4 graded outcomes Botanical Last checked
The short answer
From 9 sourcesRed raspberry leaf is widely used in late pregnancy to try to shorten labour. The only randomized trial, in 192 first-time mothers, found it did not shorten the first stage of labour and reported no adverse effects, though it was too small to rule out uncommon harms. A leaf extract missed its main knee-pain outcome. Evidence is thin.
Every graded outcome on this page
4 rows · line = participantsKey facts
- Labour
- Tablets of 2 x 1.2 g/day from 32 weeks did not shorten the first stage of labour in 192 first-time mothers; the second stage was about 9.6 minutes shorter and forceps use was lower (19.3% vs 30.4%); a systematic review notes these differences were not statistically significant12
- Safety in pregnancy
- No adverse effects for mother or baby were found in the trial, but a systematic review judged the overall evidence weak12
- How common
- About 37-38% of women surveyed in Australian maternity settings used raspberry leaf during pregnancy, mainly to make labour easier67
- Knee osteoarthritis
- 400 mg/day of a leaf extract lowered walking knee pain versus placebo over 12 weeks in 198 people, but the primary WOMAC pain score did not differ5
- After-meal glucose
- 10 g of raspberry leaf tea taken with sucrose lowered glucose at 15 and 30 minutes in 22 healthy adults; there was no effect with glucose4
- Breastfeeding
- Promoted to boost milk supply, but LactMed found no valid clinical trials supporting this and no safety data in nursing mothers or infants8
What it is
Red raspberry leaf is the dried leaf of the European red raspberry (Rubus idaeus), used as a tea or tablet, most often late in pregnancy.
How it works
ProposedLaboratory studies show raspberry leaf affects smooth muscle, including uterine muscle, in animal and human tissue. Leaf polyphenols such as ellagitannins inhibit carbohydrate-digesting enzymes, which the tea study authors propose explains the blunted sugar response. Neither effect has been linked to clinical outcomes.24
Forms, side by side
3 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.
Red raspberry leaf (Rubus idaeus) forms compared
3 forms| 3 forms | Dried leaf tablets | Leaf tea (infusion) | Ethanolic leaf extract |
|---|---|---|---|
| Absorption in people | No human absorption data.1 | A 10 g infusion supplied about 38 mg ellagitannins, 7 mg flavonoids and 4 mg phenolic acids.4 | Not measured.5 |
| GI tolerance | No adverse effects for mother or baby at 2.4 g/day from 32 weeks.1 | Single doses only in the glucose study.4 | Well tolerated at 200-400 mg/day for 12 weeks.5 |
| Studied for | Labour | After-meal glucose; traditional use in pregnancy | Knee osteoarthritis pain |
- Dried leaf tablets
- Leaf tea (infusion)
- Ethanolic leaf extract
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
4 graded outcomes, largest study first4 graded outcomes: 2 improved, 2 mixed. The largest, a 2022 randomized trial of 198 people on knee pain in osteoarthritis, found mixed results.
1Knee pain in osteoarthritis
Mixed · Grade C · RCT, 198 people, 2022
Adults with knee (femorotibial) osteoarthritis
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Knee pain in osteoarthritis | Mixed | 198 | Grade C · RCT, 2022 | Adults with knee (femorotibial) osteoarthritis |
| Length of labour and birth outcomes | Mixed | 192 | Grade C · RCT, 2001 | Low-risk first-time mothers in Sydney, Australia |
| Medical augmentation of labour | Improved | 91 | Grade D · Observational, 2024 | Pregnant women in an Australian maternity service (44 users, 47 non-users) |
| Glucose and insulin after sucrose or glucose | Improved | 22 | Grade D · Crossover RCT, 2025 | Healthy adults (12 men, 10 women) in the UK |
Every graded row
4 rowsShowing 4 of 4 outcomes. Human trials only.
CGrade CKnee pain in osteoarthritisJoint painPrimary pain score not metRCT
n 198 · 2022
Mixed WOMAC pain (primary outcome) did not differ from placebo. At 400 mg, walking knee pain on a visual scale fell by more than 7 mm versus placebo. No differences in function, stiffness, walking or quality of life. Well tolerated.
- Design
- RCT, n = 198, 2022
- Population
- Adults with knee (femorotibial) osteoarthritis
- Form
- Ethanolic Rubus idaeus leaf extract
- Dose
- 200 or 400 mg once daily
- Duration
- 12 weeks
- Source
- Reference 5 · PubMed 35799169 (opens PubMed)
CGrade CLength of labour and birth outcomesLabourFirst stage not shorterRCT
n 192 · 2001
Mixed No adverse effects for mother or baby. The first stage of labour was not shortened. The second stage was 9.59 minutes shorter and forceps deliveries were less common (19.3% vs 30.4%), the only differences the authors called clinically significant; no significant relationship with birth outcomes overall.
- Design
- RCT, n = 192, 2001
- Population
- Low-risk first-time mothers in Sydney, Australia
- Form
- Raspberry leaf tablets
- Dose
- 2 x 1.2 g per day from 32 weeks' gestation until labour
- Duration
- About 8 weeks (32 weeks to labour)
- Source
- Reference 1 · PubMed 11370690 (opens PubMed)
DGrade DMedical augmentation of labourLabourLess augmentation (observational)Observational
n 91 · 2024
Improved Users were less likely to have labour augmented, epidurals, instrumental births or caesareans, and labours were shorter. The authors say the results cannot be generalised and are not evidence of safety.
- Design
- Observational, n = 91, 2024
- Population
- Pregnant women in an Australian maternity service (44 users, 47 non-users)
- Form
- Raspberry leaf (self-selected use)
- Dose
- Self-selected
- Duration
- During pregnancy
- Source
- Reference 3 · PubMed 38649906 (opens PubMed)
DGrade DGlucose and insulin after sucrose or glucoseBlood glucoseLower early glucose with sucroseCrossover RCT
n 22 · 2025
Improved With sucrose, glucose was 1.19 and 2.03 mmol/L lower at 15 and 30 minutes and insulin lower at 15 and 60 minutes; no significant effect with glucose.
- Design
- Crossover RCT, n = 22, 2025
- Population
- Healthy adults (12 men, 10 women) in the UK
- Form
- Raspberry leaf tea (10 g leaf, 5-minute infusion, about 50 mg polyphenols)
- Dose
- 10 g leaf as tea with 50 g sucrose or glucose
- Duration
- Single dose, four sessions
- Source
- Reference 4 · PubMed 40944237 (opens PubMed)
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
What Red raspberry leaf meets
0 cited rows 1 tested togetherMedicines 0
No medicine rows in our sources.
Supplements and foods 1
- Tested together in a graded trial
Choose a medicine or supplement above to read its cited rows here.
Also cited: 1 tested together
Slippery elmSlippery elm page
Tested together
Digestive symptoms and body composition (detox blend with slippery elm). Graded on the Slippery elm page; tested together is not a claim that they work better together.
Interactions
0 agentsNone found in our sources.
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Red raspberry leaf and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Red raspberry leaf.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
5 groups- Pregnancy before the third trimester
- The only randomized trial started at 32 weeks. Raspberry leaf acts on uterine muscle in lab studies, and use earlier in pregnancy has not been tested in a trial. It is not a proven way to start labour, and a 2023 review notes a possible negative effect on cervical ripening.129
- Higher-risk pregnancies
- The randomized trial enrolled only low-risk first-time mothers, so it tells us nothing about women with complicated pregnancies, a history of preterm labour, or a previous caesarean. Raise raspberry leaf with your midwife or obstetrician before using it in those situations.1
- Pregnancy in general
- No harms were seen in the trial or a small cohort, but reviewers and the cohort authors say this is not proof of safety; it is a decision to make with a midwife or doctor.23
- Breastfeeding
- LactMed says raspberry leaf is a purported milk booster with no scientifically valid trials behind it; it is generally without side effects as a tea, but no data exist on safety in nursing mothers or their infants.8
- High-dose or injected use
- Toxicity appeared in animal studies only when high doses were given into a vein or the abdomen; there are no human data at high doses.2
How to read the label
What to check on the Supplement Facts panel.
How to read the label
1 checksFrequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
7 answersDoes raspberry leaf tea shorten labour?
Does it help joint pain?
One 12-week trial of a leaf extract missed its main pain outcome, though the 400 mg dose lowered walking knee pain. The trial was industry-linked.5
Does raspberry leaf tea increase breast milk?
There is no good evidence. LactMed says it is promoted as a milk booster but no scientifically valid clinical trials support this, and safety in nursing mothers and infants has not been studied.8
Does raspberry leaf interact with medicines?
Is raspberry leaf safe in pregnancy?
When in pregnancy was it studied?
The randomized trial started at 32 weeks of pregnancy and continued until labour. Earlier use has not been tested in a trial.1
Is raspberry leaf the same as raspberry ketone?
No. Raspberry leaf is the dried leaf of Rubus idaeus; raspberry ketone is a flavour compound sold for weight loss, with separate evidence.1
Sources
9 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
9 sources- 1Raspberry leaf in pregnancy: its safety and efficacy in labor.RCT J Midwifery Womens Health, 2001 · PMID 11370690
- 2Biophysical effects, safety and efficacy of raspberry leaf use in pregnancy: a systematic integrative review.Systematic review BMC Complement Med Ther, 2021 · PMID 33563275
- 3Raspberry leaf (Rubus idaeus) use in pregnancy: a prospective observational study.Observational BMC Complement Med Ther, 2024 · PMID 38649906
- 4Effects of Raspberry Leaf Tea Polyphenols on Postprandial Glucose and Insulin Responses in Healthy Adults.Crossover RCT Nutrients, 2025 · PMID 40944237
- 5Rubus idaeus extract improves symptoms in knee osteoarthritis patients: results from a phase II double-blind randomized controlled trial.RCT BMC Musculoskelet Disord, 2022 · PMID 35799169
- 6Survey of Raspberry Leaf Tea in pregnancy.Observational Aust N Z J Obstet Gynaecol, 2022 · PMID 35188267
- 7Beyond prescription medicine in pregnancy - raspberry leaf and other herbs in Australia.Observational BMC Complement Med Ther, 2026 · PMID 41668030
- 8Raspberry (Drugs and Lactation Database, LactMed)Database National Institute of Child Health and Human Development (LactMed), 2024 · ncbi.nlm.nih.gov
- 9Raspberry Leaves and Extracts-Molecular Mechanism of Action and Its Effectiveness on Human Cervical Ripening and the Induction of Labor.Review Nutrients, 2023 · PMID 37513625
What changed
Every dated change to this page: what changed, who made it and why.
Change log
2 entries| Date | Change | Who and why |
|---|---|---|
| key facts, who should be careful, FAQ | Added the LactMed raspberry record for breastfeeding (NBK501785) and a 2023 review on cervical ripening and labour induction (PMID 37513625); two new FAQs on milk supply and medicines. PubMed search for 2021–2026 trials and meta-analyses found no new randomized trial of the leaf. No drug interactions are listed in LactMed, the 2021 systematic review or the trial reports. | Writer: Kymata Health EditorialTrigger: A–Z page audit |
| all | Initial editorial evidence review (first draft). Every PMID checked against NCBI E-utilities esummary (titles and years taken from the record, none retracted) and the abstract read for each cited row. Studied doses are reported as research doses, not dosing advice. | Writer: Kymata Health EditorialTrigger: new page |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.